Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen andHelicobacter pyloriantibody titer

Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis

(2013) Takeichi Yoshida et al.   Gastric Cancer

Cancer Incidence and Incidence Rates in Japan in 2007: A Study of 21 Population-based Cancer Registries for the Monitoring of Cancer Incidence in Japan (MCIJ) Project

(2013) A. Matsuda et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen andHelicobacter pyloriantibody together with endoscopic rugal hyperplastic gastritis

(2012) Mika Watanabe et al.   INTERNATIONAL JOURNAL OF CANCER

Low Prevalence of Helicobacter pylori-negative Gastric Cancer among Japanese

(2011) Taiji Matsuo et al.   HELICOBACTER

The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori

(2010) Susumu Take et al.   JOURNAL OF GASTROENTEROLOGY

Eradication ofHelicobacter pyloriprevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels

(2009) Kimihiko Yanaoka et al.   INTERNATIONAL JOURNAL OF CANCER

Cancer High-Risk Subjects Identified by Serum Pepsinogen Tests: Outcomes after 10-Year Follow-up in Asymptomatic Middle-Aged Males

(2008) K. Yanaoka et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Gastric Cancer Risk in Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study in the Netherlands

(2008) Annemarie C. de Vries et al.   GASTROENTEROLOGY

Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen andHelicobacter pyloriantibody levels

(2008) Kimihiko Yanaoka et al.   INTERNATIONAL JOURNAL OF CANCER